ClinicalTrials.Veeva

Menu
North America Research Institute | NARI San Dimas, CA - Other PI's logo

North America Research Institute | NARI San Dimas, CA - Other PI's

Research site

Site insights

Top conditions

Top treatments

Clazakizumab
Apricoxib
Lanthanum Carbonate
Gemcitabine
Calcifediol
Capecitabine
Vicadrostat
SNF472
MK-2060
Sugar

Parent organization

This site is a part of North America Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Molly Way

Verified by this site

Active trials

7 of 21 total trials

A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both (AMBITION 2)

The study is testing zenagamtide in participants with type 2 diabetes and chronic kidney disease. The purpose of this clinical study is to find out i...

Not yet enrolling
Chronic Kidney Disease
Type 2 Diabetes
Other: Placebo
Drug: Zenagamtide

This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receivi...

Enrolling
End Stage Renal Disease on Dialysis
Chronic Kidney Disease Requiring Chronic Dialysis
Drug: AP306 75 mg TID
Drug: AP306 150 mg BID

PODOMOUNT-pFSGSThis study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of...

Enrolling
Focal Segmental Glomerulosclerosis
Drug: BI 764198
Drug: Placebo

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study.Part 1...

Enrolling
End Stage Kidney Disease
Drug: Placebo
Drug: CSL300

The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by t...

Enrolling
End Stage Kidney Disease
Device: Moda-flx Hemodialysis System™

This study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on participants who have diabetic kidney d...

Enrolling
Diabetic Kidney Disease (DKD)
Drug: Evinacumab
Drug: ALN-ANG3

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week...

Enrolling
CDI
C.Difficile Diarrhea
Biological: Placebo
Biological: VE303

Trial sponsors

Boehringer Ingelheim logo
CSL Behring logo
Novo Nordisk logo
T
C
I
Merck Sharp & Dohme (MSD) logo
OPKO Health logo
P
Regeneron Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems